Evidence map›Paper›PMID 24995868›Full record

ArticleAmerican journal of human genetics2014

Targeted resequencing and systematic in vivo functional testing identifies rare variants in MEIS1 as significant contributors to restless legs syndrome.

Eva C Schulte, Maria Kousi, Perciliz L Tan, Erik Tilch, Franziska Knauf, Peter Lichtner, Claudia Trenkwalder, Birgit Högl, Birgit Frauscher, Klaus Berger and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 4 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 4 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Putative Animal Models of Restless Legs Syndrome: A Systematic Review and Evaluation of Their Face and Construct Validity.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Polygenic risk scores in neurological disorders: restless legs syndrome as a translational model.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2026
    Article
  6. Review
  7. Association between inflammatory cytokines and disease severity in restless legs syndrome.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  8. Article
  9. Genomic analysis identifies risk factors in restless legs syndrome.medRxiv : the preprint server for health sciences · 2023
    Article
  10. Article
  11. Article
  12. Frontiers in neurology · 2019
    Review
  13. Article
  14. Disease models & mechanisms · 2017
    Article
  15. Article
  16. Article
  17. Animal models of RLS phenotypes.Sleep medicine · 2017
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 13 institutions in 4 countries.

Eva C SchulteNeurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany; Institut für Humangenetik, Helmholtz Zentrum München, 85764 Munich, Germany.
Maria KousiCenter for Human Disease Modeling, Department of Cell Biology, Duke University, Durham, NC 27710, USA.
Perciliz L TanCenter for Human Disease Modeling, Department of Cell Biology, Duke University, Durham, NC 27710, USA.
Erik TilchInstitut für Humangenetik, Helmholtz Zentrum München, 85764 Munich, Germany; Institut für Humangenetik, Technische Universität München, 81675 Munich, Germany.
Franziska KnaufInstitut für Humangenetik, Helmholtz Zentrum München, 85764 Munich, Germany.
Peter LichtnerInstitut für Humangenetik, Helmholtz Zentrum München, 85764 Munich, Germany; Institut für Humangenetik, Technische Universität München, 81675 Munich, Germany.
Claudia TrenkwalderParacelsus Elena Klinik, 34128 Kassel, Germany; Klinik für Neurochirurgie, Georg August Universität, 37075 Göttingen, Germany.
Birgit HöglDepartment of Neurology, Medizinische Universität Innsbruck, 6020 Innsbruck, Austria.
Birgit FrauscherDepartment of Neurology, Medizinische Universität Innsbruck, 6020 Innsbruck, Austria.
Klaus BergerInstitut für Epidemiologie und Sozialmedizin, Westfälische Wilhelms Universität Münster, 48149 Münster, Germany.
Ingo FietzeZentrum für Schlafmedizin, Charité Universitätsmedizin, 10117 Berlin, Germany.
Magdolna HornyakNeurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany; Interdisziplinäres Schmerzzentrum, Albert-Ludwigs Universität Freiburg, 79106 Freiburg, Germany; Diakoniewerk München-Maxvorstadt, 80799 Munich, Germany.
Wolfgang H OertelKlinik für Neurologie, Philipps Universität Marburg, 35039 Marburg, Germany.
Cornelius G BachmannAbteilung für Neurologie, Paracelsus Klinikum Osnabrück, 49076 Osnabrück, Germany; Klinische Neurophysiologie, Georg August Universität, 37075 Göttingen, Germany.
Alexander ZimprichDepartment of Neurology, Medizinische Universität Wien, 1090 Vienna, Austria.
Annette PetersInstitute of Epidemiology II, Helmholtz Zentrum München, 85764 Munich, Germany.
Christian GiegerInstitute of Genetic Epidemiology, Helmholtz Zentrum München, 85764 Munich, Germany.
Thomas MeitingerInstitut für Humangenetik, Helmholtz Zentrum München, 85764 Munich, Germany; Institut für Humangenetik, Technische Universität München, 81675 Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Bertram Müller-MyhsokMunich Cluster for Systems Neurology (SyNergy), Munich, Germany; Max-Planck Institut für Psychiatrie München, 80804 Munich, Germany; Institute of Translational Medicine, University of Liverpool, Liverpool L69 3BX, UK.
Nicholas KatsanisCenter for Human Disease Modeling, Department of Cell Biology, Duke University, Durham, NC 27710, USA.
Juliane WinkelmannNeurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany; Institut für Humangenetik, Helmholtz Zentrum München, 85764 Munich, Germany; Institut für Humangenetik, Technische Universität München, 81675 Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Department of Neurology and Neurosciences, Center for Sleep Sciences and Medicine, Stanford University, Palo Alto, CA 94304, USA. Electronic address: winkelmann@stanford.edu.
Helmholtz Zentrum München · DEDuke University · USKlinikum rechts der Isar · DEInnsbruck Medical University · ATCharité - Universitätsmedizin Berlin · DEKlinikum Osnabrück · DEMedical University of Vienna · ATMunich Cluster for Systems Neurology · DEPhilipps University of Marburg · DETechnical University of Munich · DEUniversity of Göttingen · DEUniversity of Liverpool · GBUniversity of Münster · DE

Funding

Project 3P50MH094268 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2011 to 2020
$19.9M
NIMH NIH HHS P50 MH094268
6 · The paper itself

Abstract

Restless legs syndrome (RLS) is a common neurologic condition characterized by nocturnal dysesthesias and an urge to move, affecting the legs. RLS is a complex trait, for which genome-wide association studies (GWASs) have identified common susceptibility alleles of modest (OR 1.2-1.7) risk at six genomic loci. Among these, variants in MEIS1 have emerged as the largest risk factors for RLS, suggesting that perturbations in this transcription factor might be causally related to RLS susceptibility. To establish this causality, direction of effect, and total genetic burden of MEIS1, we interrogated 188 case subjects and 182 control subjects for rare alleles not captured by previous GWASs, followed by genotyping of ∼3,000 case subjects and 3,000 control subjects, and concluded with systematic functionalization of all discovered variants using a previously established in vivo model of neurogenesis. We observed a significant excess of rare MEIS1 variants in individuals with RLS. Subsequent assessment of all nonsynonymous variants by in vivo complementation revealed an excess of loss-of-function alleles in individuals with RLS. Strikingly, these alleles compromised the function of the canonical MEIS1 splice isoform but were irrelevant to an isoform known to utilize an alternative 3' sequence. Our data link MEIS1 loss of function to the etiopathology of RLS, highlight how combined sequencing and systematic functional annotation of rare variation at GWAS loci can detect risk burden, and offer a plausible explanation for the specificity of phenotypic expressivity of loss-of-function alleles at a locus broadly necessary for neurogenesis and neurodevelopment.

Indexed as

AnimalsGenetic Complementation TestGenotypeHomeodomain ProteinsHumansIn Situ HybridizationMass SpectrometryMyeloid Ecotropic Viral Integration Site 1 ProteinNeoplasm ProteinsRestless Legs SyndromeZebrafishHomeodomain ProteinsMEIS1 protein, humanMyeloid Ecotropic Viral Integration Site 1 ProteinNeoplasm Proteins

Identifiers

PMID24995868
PMCPMC4085638
OpenAlexW2144960925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.